Abstract: Methods, systems, and apparatus, including computer programs encoded on a storage device, for using a drone to test monitoring system sensors. In one aspect, the drone perform operations that include navigating from a first location of a property towards a second location of the property, detecting a sensor that is installed at the property, interrupting, by the drone, navigation through the property from the first location of the property towards the second location of the property to initiate a test of the detected sensor and (ii) determining a sensor test type for the detected sensor, administering a sensor test to the detected sensor, wherein the sensor test is based on the determined sensor test type, evaluating results of the administered test, storing data describing the results of the administered test, and continuing navigation through the property towards the second location of the property or towards another location of the property.

Abstract: A conveyor module 1, adapted to be releasably attached to at least one other conveyor module 1 to form a conveyor assembly 15. Each conveyor module 1 includes a substantially longitudinal main frame 4, said main frame 4 being adjustable between a first position (FIG. 3), in which said module 1 is compacted for transportation, and, a second position (FIG. 4), in which said module 1 is expanded for conveyor operation. A plurality of support legs 17 is provided to support said conveyor module 1 upon a substrate surface, each support leg being adjustable to facilitate adjustable alignment of said module 1. Conveyor componentry 12 is housed substantially within said main frame 1. The conveyor module 1 is preferably formed from or built to standardised shipping container (ISO) specifications.

Abstract: A conveyor module 1, adapted to be releasably attached to at least one other conveyor module 1 to form a conveyor assembly 15. Each conveyor module 1 includes a substantially longitudinal main frame 4, said main frame 4 being adjustable between a first position (FIG. 3), in which said module 1 is compacted for transportation, and, a second position (FIG. 4), in which said module 1 is expanded for conveyor operation. A plurality of support legs 17 is provided to support said conveyor module 1 upon a substrate surface, each support leg being adjustable to facilitate adjustable alignment of said module 1. Conveyor componentry 12 is housed substantially within said main frame 1. The conveyor module 1 is preferably formed from or built to standardised shipping container (ISO) specifications.

Abstract: A conveyor module (1), adapted to be releasably attached to at least one other conveyor module (1) to form a conveyor assembly (15). Each conveyor module (1) includes a substantially longitudinal main frame (4), said main frame (4) being adjustable in between a first position (FIG. 3), in which said module (1) is compacted for transportation, and, a second position (FIG. 4), in which said module (1) is expanded for conveyor operation. A plurality of support legs (17) is provided to support said conveyor module (1) upon a substrate surface, each support leg being adjustable to facilitate adjustable alignment of said module (1). Conveyor componentry (12) is housed substantially within said main frame (1). The conveyor module (1) is preferably formed from or built to standardised shipping container (ISO) specifications.

Abstract: A conveyor module (1), adapted to be releasably attached to at least one other conveyor module (1) to form a conveyor assembly (15). Each conveyor module (1) includes a substantially longitudinal main frame (4), said main frame (4) being adjustable in between a first position (FIG. 3), in which said module (1) is compacted for transportation, and, a second position (FIG. 4), in which said module (1) is expanded for conveyor operation. A plurality of support legs (17) is provided to support said conveyor module (1) upon a substrate surface, each support leg being adjustable to facilitate adjustable alignment of said module (1). Conveyor componentry (12) is housed substantially within said main frame (1). The conveyor module (1) is preferably formed from or built to standardised shipping container (ISO) specifications.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: Systems and methods for determining the trustworthiness of calling party information, such as caller ID and ANI information, contained in a call request are provided. The method includes receiving a call request at a service provider network element, such as a telecommunication carrier switch. A decision is made as to whether the call request should be verified by reviewing a database of called telephone numbers for monitoring. When the call request is to be verified, a determination is made whether a discrepancy exists between the calling party information contained within the call request and authenticated stored calling party information. For example, the caller ID information in a call request is compared to service provider caller ID information for the calling party to determine if they match. When a discrepancy exists, a discrepancy report is transmitted to the called party.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: Systems and methods for determining the trustworthiness of calling party information, such as caller ID and ANI information, contained in a call request are provided. The method includes receiving a call request at a service provider network element, such as a telecommunication carrier switch. A decision is made as to whether the call request should be verified by reviewing a database of called telephone numbers for monitoring. When the call request is to be verified, a determination is made whether a discrepancy exists between the calling party information contained within the call request and authenticated stored calling party information. For example, the caller ID information in a call request is compared to service provider caller ID information for the calling party to determine if they match. When a discrepancy exists, a discrepancy report is transmitted to the called party.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: Identifying the information associated with a number of different user accounts may provide the basis for automatically generating a chat session based on that information. In one example method of operation a number of users may be identified as potential candidates for a chat session via an automated agent application and an attribute of each of the users may be retrieved from memory that shares a common interest identifier with the other users. The chat session can then be created based on the common interest identifier, and a notification can be transmitted to each of the users to invite them to the chat session.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: The present invention provides a compound of formula I; or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.

Abstract: The invention provides compounds of formula (I) wherein R is as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals, for use in the treatment of any state associated with high levels of activeted PARP.

Abstract: The invention provides compounds of formula (I) wherein R is as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals, for use in the treatment of any state associated with high levels of activeted PARP.

Abstract: An apparatus for measuring the velocity of fluid flowing in a fluid path, includes a signal generator for generating input signals, and two ultrasonic transducers coupled diagonally across the fluid path. The transducers are connected in series to the signal generator such that equal and opposite input signals are simultaneously applied to each transducer. A signal processor combines the output signals of each transducer caused by the ultrasonic signal transmitted by the other transducer across the fluid path to obtain a destructive interference signal and a constructive interference signal, and compares the amplitude of the destructive interference signal with the amplitude of the constructive interference signal to obtain a measure of the velocity of the fluid. The signal processor may also compare the phase of the destructive interference signal with the phase of the constructive interference signal to obtain a measure of the direction of flow.